INTRODUCTION
Our understanding of the pathogenesis of fever has advanced considerably in recent years, but the question of what the mammalian host gains by this metabolically costly response to infection remains largely unanswered [1, 2] . Fever caused by most exogenous agents is mediated by a hormone-like polypeptide produced by host macrophages or monocytes. This mediator, called endogenous pyrogen (EP), produces a controlled rise in body temperature through an action on the thermoregulatory area of the brain [3] .
Interleukin 1 (ILl -formerly called Lymphocyte Activating Factor) is a peptide of macrophage origin that stimulates T-lymphocyte proliferation in the presence of lectin or antigen and so enhances, or may even be essential for, immune responses [4, 5, 6] . The mitogenic action of ILI on T cells is probably mediated by the lymphocyte product interleukin 2 (IL2) [7] . There is now substantial evidence, based on functional and biochemical properties, to indicate that EP and ILl are identical [8, 9] .
We postulated that the pyrogenic and T-cell mitogenic properties of this macrophage-derived mediator (EP/ILI) may be functionally interrelated and tested the effect of increased temperature on T-cell proliferation stimulated by ILI or IL2. We found that T-cell proliferation in response to either ILl or IL2 in the presence of concanavalin A (Con A) was greatly increased at 39°C compared to 37°C, while B-cell proliferation stimulated by lipopolysaccharide (LPS) was not. Therefore ILI, the endogenous mediator of fever, also stimulated T-cell proliferation that was highly temperature-dependent over the range of temperature characteristic of natural fever. These findings suggest a potentially important immunoregulatory function of the fever response.
MATERIALS AND METHODS
ILl was prepared by stimulating P388D1 macrophage-like murine tumor cells with LPS (20 ,g/ml, E. coli, Difco) for four days [10] . Supernatants were precipitated with 65 percent saturated ammonium sulphate, dialyzed against phosphatebuffered saline and fractionated by gel filtration chromatography over G75 Superfine Sephadex (Pharmacia). ILI activity was found in the 15-20,000 MW fractions and stored at -20°C until used. The final concentrations of ILl used were 0.2, 1, and 5 percent by volume, corresponding to 5, 25, and 125 units/ml, approximately [11] . Crude human ILl-containing supernatants from LPS-stimulated blood monocytes were also tested.
IL2 was obtained from the T-cell hybridoma FS6-14.13 [12] . Hybridoma cells were cultured with Con A (2 Ag/ml) for 24 hours (in the absence of serum), and the supernatants were checked for IL2 activity by maintenance of Con A-induced blast cells [13] or maintenance of the IL2-dependent T-cell line HT-2 [14] (HT-2 cell line was a gift of Dr. John Ryan, New Haven, CT, and FS6-14. 13 hybridoma was kindly donated by Drs. J. Kappler and P. Marrack, Denver, CO). Crude IL2-containing supernatants from Con A-stimulated (5 ,tg/ml) rat spleen cells were also used.
Proliferation assays were performed with thymocytes or spleen cells from C3H/ HeJ (LPS-hyporesponsive) mice or spleen cells from C57BL/6J (LPS-responders).
Cells were cultured in 200 j1 RPMI with 10 percent fetal calf serum in microtiter wells with different concentrations of ILl or IL2 and Con A for two or three days at 370 or 39°C, and then assayed for proliferation by uptake of tritiated thymidine following a five-hour pulse with 1 ytCi 3H thymidine (performed at 37°C in all cases-for details, see figure legends). The proliferative responses of C57BL6 spleen cells stimulated with LPS (E. coli) were assayed in the same way. All cultures were performed in gas-tight boxes within thermostatically controlled incubators ( 0.2QC).
The boxes were flushed with a 10 percent CO2, 90 percent air mixture for two minutes daily. Cell (FS6-14.13) plus the T-cell mitogen, Con A, was also increased at the higher temperature (Fig. 2) , but the maximum increases (four-to fivefold in eight experiments) were usually lower than those that occurred with thymocytes.
Splenic B-Cell Proliferation and Kinetics of Response
To test the possibility that the proliferation of any type of lymphocyte may be increased at 39°C, we examined the mitogenic response of splenic B-cells to the polyclonal B-cell mitogen, LPS. At 39°C, LPS-induced, B-cell proliferation (assayed on day 3) was consistently reduced compared to the responses obtained at 37°C (Fig. 3) . For comparison, the proliferative responses of the same spleen cells (T-cell responses) to ILI and Con A in the same experiment are also shown (Fig. 3) . In eight experiments, LPS-induced, B-cell proliferation at three days was reduced at 39°C compared to 37°C. The maximum response of splenic B-cells to LPS at 37°C occurred variably on either the second or third day of culture (upper panel of Table 1 shows a three-day maximum). In either case, proliferation increased only modestly, 25 if at all, at 39°C and only on the day preceding the peak response (never more than twofold). Table 1 (bottom panel) . Culture of T-cells at 39°C did not change the day of maximum response (day 3), indicating a temperature-dependent augmentation of the total proliferative response of T cells to ILI rather than an acceleration of response. These findings demonstrate that, at least with the mitogens used, the marked augmenting effect of raised temperature on lymphocyte proliferation was selective for T cells. DISCUSSION Beneficial effects of hyperthermia on lymphocyte proliferation in response to lectins or antigen have been described previously [15, 16, 17] and we have summarized some of the findings described here in a short preliminary report [18] . We now report that T-cell proliferation induced by either ILI, the "endogenous pyrogen," or the lymphokine mediator, IL2, is greatly increased by hyperthermia.
Since IL2-induced T-cell proliferation was augmented by the higher temperature, the effect of hyperthermia on IL1-induced proliferation cannot be attributed solely to increased production of IL2 but is likely to be, at least in part, a property of the T-cell subset that proliferates in response to IL2.
The temperatures used in these experiments correspond to the normal body temperature of the resting mouse (37°C) and the temperature of mice during fever produced by an exogenous pyrogen (LPS) or human endogenous pyrogen (39°C) ( [19] and Duff GW, Stitt J, Durum SK, unpublished observations).
It seems, therefore, that the mitogenic action of ILI that causes clonal expansion of T lymphocytes is greatly increased at higher temperatures, such as those that occur in natural fevers. Moreover, the production of fever itself is governed by the central nervous system in response to a direct or indirect signal provided by ILl [3] . This functional interaction of these two biological properties of ILl, pyrogenicity and T-cell mitogenicity, could have important immunoregulatory consequences depending upon the subsets of T cells involved. We have found, for example, that hyperthermia dramatically improves the primary in vitro humoral immune response. This augmentation appears to result from an increased generation of T helper cells rather than enhanced B-cell activation or impaired T suppressor cell function ( [20] and Jampel HD, Duff GW, Gershon RK, et al., submitted for publication).
Our current objectives include the characterization, by membrane phenotype and lymphokine production, of T-cell subsets affected by hyperthermia and the identification of relevant temperature-dependent biochemical events. We have already reported a marked, rapid effect of hyperthermia on T-cell protein synthesis [21] .
Fever, as a host defense, has recently been reviewed by several authors [2, 22, 23] and has been shown to correlate both with survival [24, 25] and with the development of an earlier tissue inflammatory response in infected animals [26] . If naturally occurring fever influences the immune response in vivo to the extent suggested by our observations in vitro, then the role of fever as a host defense may warrant further examination. For example, antipyretic drugs may be useful in auto-immune diseases where the immune response is detrimental to the host; but when the immune response is to the host's advantage (e.g., directed against infections or neoplastic cells), then fever may itself be beneficial.
